Biotech

All Articles

' Medical instinct' led FDA advisors to back Zevra's uncommon ailment med

.Zevra Therapies' unusual disease drug seems to be to become on the pathway to permission this autum...

Pfizer takes $230M hit after axing stopped working DMD gene therapy

.Pfizer's period 3 Duchenne muscle dystrophy (DMD) genetics treatment failing has gone a $230 thousa...

AC Immune views 'site' prospective in Alzheimer's drug data

.After greater than two decades of focus on neurodegenerative illness, Swiss biotech AC Immune syste...

GSK falls ph. 2 HPV vaccine over absence of best-in-class potential

.GSK has junked a stage 2 individual papillomavirus (HPV) vaccine from its own pipe after choosing t...

OS Treatments refiles $6M IPO to finance HER2 medicine, preclinical ADCs

.Operating system Therapies will list on the NYSE American inventory substitution this morning using...

ALX's waning CD47 response rate sends out sell spiraling down

.ALX Oncology's stage 2 gastric cancer cells reaction fee has deteriorated. After seeing its CD47 bl...

Ionis centers eye illness from aim ats of Roche-partnered prospect after records disappoint

.Another of Ionis Pharmaceuticals' crucial midphase readouts has actually fallen short of expectatio...

Biogen's CEO stated no risky sell 2023. He prepares to be daring

.While Biogen's pharma peers are hunting for late-stage assets with little danger, chief executive o...

Instil refills pipe in $2B biobucks handle ImmunOnco

.Instil Bio has been a biotech in search of a pipeline after it junked its lead possessions over the...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually returned legal rights to an early Alzheimer's disease system to Denali Therapeu...